Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.

Gao B, Yu T, Xue D, Sun B, Shao Q, Choudhry H, Marcus V, Ragoussis J, Zhang Y, Zhang W, Gao ZH.

PLoS One. 2017 Jun 19;12(6):e0178760. doi: 10.1371/journal.pone.0178760. eCollection 2017.

2.

Sinusoidal endotheliitis as a histological parameter for diagnosing acute liver allograft rejection.

Shi Y, Dong K, Zhang YG, Michel RP, Marcus V, Wang YY, Chen Y, Gao ZH.

World J Gastroenterol. 2017 Feb 7;23(5):792-799. doi: 10.3748/wjg.v23.i5.792.

3.

[Corrigendum] Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.

Gao B, Shao Q, Choudhry H, Marcus V, Dong K, Ragoussis J, Gao ZH.

Int J Oncol. 2017 Jan;50(1):339. doi: 10.3892/ijo.2016.3722. Epub 2016 Oct 6.

4.

Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.

Gao B, Shao Q, Choudhry H, Marcus V, Dong K, Ragoussis J, Gao ZH.

Int J Oncol. 2016 Sep;49(3):1108-18. doi: 10.3892/ijo.2016.3591. Epub 2016 Jun 30. Erratum in: Int J Oncol. 2017 Jan;50(1):339.

PMID:
27571956
5.

Cytomegalovirus-induced Colon Perforation in Systemic Lupus Erythematosus.

Glushko T, Marcus VA, Colmegna I.

J Rheumatol. 2016 Feb;43(2):459-60. doi: 10.3899/jrheum.150964. No abstract available.

PMID:
26834256
6.

Decreased PCSK9 expression in human hepatocellular carcinoma.

Bhat M, Skill N, Marcus V, Deschenes M, Tan X, Bouteaud J, Negi S, Awan Z, Aikin R, Kwan J, Amre R, Tabaries S, Hassanain M, Seidah NG, Maluccio M, Siegel P, Metrakos P.

BMC Gastroenterol. 2015 Dec 16;15:176. doi: 10.1186/s12876-015-0371-6.

7.

The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.

Lobatón T, Bessissow T, De Hertogh G, Lemmens B, Maedler C, Van Assche G, Vermeire S, Bisschops R, Rutgeerts P, Bitton A, Afif W, Marcus V, Ferrante M.

J Crohns Colitis. 2015 Oct;9(10):846-52. doi: 10.1093/ecco-jcc/jjv111. Epub 2015 Jun 26.

PMID:
26116558
8.

A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.

Li L, Hamel N, Baker K, McGuffin MJ, Couillard M, Gologan A, Marcus VA, Chodirker B, Chudley A, Stefanovici C, Durandy A, Hegele RA, Feng BJ, Goldgar DE, Zhu J, De Rosa M, Gruber SB, Wimmer K, Young B, Chong G, Tischkowitz MD, Foulkes WD.

J Med Genet. 2015 May;52(5):348-52. doi: 10.1136/jmedgenet-2014-102934. Epub 2015 Feb 17.

PMID:
25691505
9.

Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population.

Castellsagué E, Liu J, Volenik A, Giroux S, Gagné R, Maranda B, Roussel-Jobin A, Latreille J, Laframboise R, Palma L, Kasprzak L, Marcus VA, Breguet M, Nolet S, El-Haffaf Z, Australie K, Gologan A, Aleynikova O, Oros-Klein K, Greenwood C, Mes-Masson AM, Provencher D, Tischkowitz M, Chong G, Rousseau F, Foulkes WD.

Clin Genet. 2015 Jun;87(6):536-42. doi: 10.1111/cge.12526. Epub 2014 Nov 22.

PMID:
25318681
10.

Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer.

Sun C, Zargham R, Shao Q, Gui X, Marcus V, Lazaris A, Salman A, Metrakos P, Qu X, Gao Z.

Pathol Res Pract. 2014 Oct;210(10):668-74. doi: 10.1016/j.prp.2014.06.016. Epub 2014 Jun 27.

PMID:
25041835
11.

Diagnostic accuracy and utility of intraoperative microscopic margin analysis of gastric and esophageal adenocarcinoma.

Spicer J, Benay C, Lee L, Rousseau M, Andalib A, Kushner Y, Marcus V, Ferri L.

Ann Surg Oncol. 2014 Aug;21(8):2580-6. doi: 10.1245/s10434-014-3669-7. Epub 2014 May 8.

PMID:
24806114
12.

Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer.

Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, Marcus VA, Bertos N, Sehat B, Perera RM, Bell ES, Page BD, Gunning PT, Ferri LE, Hallett M, Park M.

Sci Signal. 2014 Apr 22;7(322):ra38. doi: 10.1126/scisignal.2004839.

PMID:
24757178
13.

A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.

Ndao M, Nath-Chowdhury M, Sajid M, Marcus V, Mashiyama ST, Sakanari J, Chow E, Mackey Z, Land KM, Jacobson MP, Kalyanaraman C, McKerrow JH, Arrowood MJ, Caffrey CR.

Antimicrob Agents Chemother. 2013 Dec;57(12):6063-73. doi: 10.1128/AAC.00734-13. Epub 2013 Sep 23.

14.

Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome.

Alcindor T, Ferri LE, Marcus V, Andalib A, Hickeson M, Artho G, Chasen M, Thirlwell MP, Ades S.

Med Oncol. 2013 Mar;30(1):377. doi: 10.1007/s12032-012-0377-7. Epub 2012 Dec 29.

PMID:
23275118
15.

eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.

Alain T, Morita M, Fonseca BD, Yanagiya A, Siddiqui N, Bhat M, Zammit D, Marcus V, Metrakos P, Voyer LA, Gandin V, Liu Y, Topisirovic I, Sonenberg N.

Cancer Res. 2012 Dec 15;72(24):6468-76. doi: 10.1158/0008-5472.CAN-12-2395. Epub 2012 Oct 24.

16.

The impact of incidental gastrointestinal stromal tumours on patients undergoing resection of upper gastrointestinal neoplasms.

Chan CH, Cools-Lartigue J, Marcus VA, Feldman LS, Ferri LE.

Can J Surg. 2012 Dec;55(6):366-70. doi: 10.1503/cjs.009111.

17.

Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication.

Cools-Lartigue J, Chang SY, Mckendy K, Mayrand S, Marcus V, Fried GM, Ferri LE.

Dis Esophagus. 2013 Nov-Dec;26(8):766-75. doi: 10.1111/j.1442-2050.2012.01385.x. Epub 2012 Aug 14.

PMID:
22891632
18.

Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial.

Ferri LE, Ades S, Alcindor T, Chasen M, Marcus V, Hickeson M, Artho G, Thirlwell MP.

Ann Oncol. 2012 Jun;23(6):1512-7. doi: 10.1093/annonc/mdr465. Epub 2011 Oct 29.

PMID:
22039085
19.

Immunosuppression with budesonide for liver transplant recipients with severe infections.

Bhat M, Ghali P, Wong P, Marcus V, Michel R, Cantarovich M, Metrakos P, Deschenes M.

Liver Transpl. 2012 Feb;18(2):262-3. doi: 10.1002/lt.22453. No abstract available.

20.

New insights into gastrointestinal and hepatic granulomatous disorders.

Almadi MA, Aljebreen AM, Sanai FM, Marcus V, Almeghaiseeb ES, Ghosh S.

Nat Rev Gastroenterol Hepatol. 2011 Aug 5;8(8):455-66. doi: 10.1038/nrgastro.2011.115. Review.

PMID:
21818145
21.

A two-locus system controls susceptibility to colitis-associated colon cancer in mice.

Van Der Kraak L, Meunier C, Turbide C, Jothy S, Gaboury L, Marcus V, Chang SY, Beauchemin N, Gros P.

Oncotarget. 2010 Oct;1(6):436-46.

22.

Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia.

Rio Frio T, Lavoie J, Hamel N, Geyer FC, Kushner YB, Novak DJ, Wark L, Capelli C, Reis-Filho JS, Mai S, Pastinen T, Tischkowitz MD, Marcus VA, Foulkes WD.

N Engl J Med. 2010 Dec 30;363(27):2628-37. doi: 10.1056/NEJMoa1006565.

23.

Secondary intestinal lymphangiectasia due to multiple myeloma.

Bhat M, Laneuville P, Marliss EB, Costea F, Marcus V, Seidman EG, Bitton A.

Gastrointest Endosc. 2011 Sep;74(3):718-20. doi: 10.1016/j.gie.2010.09.019. Epub 2010 Nov 18. No abstract available.

PMID:
21092952
24.

Pathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapy.

Chan G, Hassanain M, Chaudhury P, Vrochides D, Neville A, Cesari M, Kavan P, Marcus V, Metrakos P.

HPB (Oxford). 2010 May;12(4):277-84. doi: 10.1111/j.1477-2574.2010.00170.x.

25.

High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.

Chong G, Jarry J, Marcus V, Thiffault I, Winocour S, Monczak Y, Drouin R, Latreille J, Australie K, Bapat B, Gordon PH, Giguère Y, Gologan A, Galiatsatos P, Jass JR, Wong N, Zaor S, Palma L, Kasprzak L, Tischkowitz M, Foulkes WD.

Hum Mutat. 2009 Aug;30(8):E797-812. doi: 10.1002/humu.21056.

PMID:
19459153
26.

The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy.

Salem SB, Kushner Y, Marcus V, Mayrand S, Fallone CA, Barkun AN.

Can J Gastroenterol. 2009 Feb;23(2):99-104.

27.

A case of Cowden's syndrome presenting with gastric carcinomas and gastrointestinal polyposis.

Al-Thihli K, Palma L, Marcus V, Cesari M, Kushner YB, Barkun A, Foulkes WD.

Nat Clin Pract Gastroenterol Hepatol. 2009 Mar;6(3):184-9. doi: 10.1038/ncpgasthep1359. Epub 2009 Feb 3.

PMID:
19190598
28.

Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery.

Palma L, Marcus V, Gilbert L, Chong G, Foulkes WD.

Gynecol Oncol. 2008 Dec;111(3):575-8. doi: 10.1016/j.ygyno.2008.08.002. Epub 2008 Sep 20.

PMID:
18805575
29.

Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1-/- mice.

Leung N, Turbide C, Balachandra B, Marcus V, Beauchemin N.

Oncogene. 2008 Aug 21;27(36):4943-53. doi: 10.1038/onc.2008.136. Epub 2008 May 5.

PMID:
18454175
30.

Liver transplantation for metastases from a bile duct carcinoid.

Tzimas GN, Vali K, Deschênes M, Marcus VA, Barkun JS, Tchervenkov JI, Metrakos PP.

HPB (Oxford). 2006;8(1):67-8. doi: 10.1080/13651820600573170.

31.

Small-cell anal carcinoma and AIDS: case report and review of the literature.

Alcindor T, Tosikyan A, Vuong T, Marcus V.

Int J Colorectal Dis. 2008 Jan;23(1):135-6. Epub 2007 Feb 6. Review. No abstract available.

PMID:
17279348
32.

Poorly differentiated tumours of the anal canal: a diagnostic strategy for the surgical pathologist.

Balachandra B, Marcus V, Jass JR.

Histopathology. 2007 Jan;50(1):163-74. Review.

PMID:
17204029
33.

Classic Kaposi's sarcoma presenting first with gastrointestinal tract involvement in a HIV-negative Inuit male--a case report and review of the literature.

Balachandra B, Tunitsky E, Dawood S, Hings I, Marcus VA.

Pathol Res Pract. 2006;202(8):623-6. Epub 2006 May 8.

PMID:
16682127
34.

Postchemotherapy characteristics of hepatic colorectal metastases: remnants of uncertain malignant potential.

Znajda TL, Hayashi S, Horton PJ, Martinie JB, Chaudhury P, Marcus VA, Jass JR, Metrakos P.

J Gastrointest Surg. 2006 Apr;10(4):483-9.

PMID:
16627212
35.

Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis.

Leung N, Turbide C, Olson M, Marcus V, Jothy S, Beauchemin N.

Oncogene. 2006 Sep 7;25(40):5527-36. Epub 2006 Apr 17.

PMID:
16619040
36.

Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases.

Tzimas GN, Chevet E, Jenna S, Nguyên DT, Khatib AM, Marcus V, Zhang Y, Chrétien M, Seidah N, Metrakos P.

BMC Cancer. 2005 Nov 17;5:149.

37.

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ.

Hepatology. 2005 Jul;42(1):53-62.

PMID:
15954109
38.

Putative common origin of two MLH1 mutations in Italian-Quebec hereditary non-polyposis colorectal cancer families.

Thiffault I, Foulkes WD, Marcus VA, Farber D, Kasprzak L, MacNamara E, Wong N, Hutter P, Radice P, Bertario L, Chong G.

Clin Genet. 2004 Aug;66(2):137-43.

PMID:
15253764
39.

Collagenous colitis with spondyloarthropathy presenting as fibromyalgia syndrome.

Christopoulos S, Marcus VA, Fitzcharles MA.

J Rheumatol. 2004 Jul;31(7):1455-6.

PMID:
15229969
40.

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.

Thiffault I, Hamel N, Pal T, McVety S, Marcus VA, Farber D, Cowie S, Deschênes J, Meschino W, Odefrey F, Goldgar D, Graham T, Narod S, Watters AK, MacNamara E, Du Sart D, Chong G, Foulkes WD.

Br J Cancer. 2004 Jan 26;90(2):483-91.

41.

Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.

Arnold CN, Goel A, Compton C, Marcus V, Niedzwiecki D, Dowell JM, Wasserman L, Inoue T, Mayer RJ, Bertagnolli MM, Boland CR.

Cancer Biol Ther. 2004 Jan;3(1):73-8. Epub 2004 Jan 5.

PMID:
14726676
42.

Laparoscopic antrectomy: a novel approach to treating watermelon stomach.

Sherman V, Klassen DR, Feldman LS, Jabbari M, Marcus V, Fried GM.

J Am Coll Surg. 2003 Nov;197(5):864-7. No abstract available.

PMID:
14585429
43.

The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, Marcus V, Tomsho L, Gebert J, Macrae FA, Gaff CL, Paillerets BB, Gregersen PK, Weitzel JN, Gordon PH, MacNamara E, King MC, Hampel H, De La Chapelle A, Boyd J, Offit K, Rennert G, Chong G, Ellis NA.

Am J Hum Genet. 2002 Dec;71(6):1395-412. Epub 2002 Nov 26.

44.

The atypical colitides.

Waschke KA, Marcus VA, Bitton A.

Gastroenterol Clin North Am. 2002 Mar;31(1):293-305. Review.

PMID:
12122739
45.

Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis.

Thompson-Fawcett MW, Marcus V, Redston M, Cohen Z, McLeod RS.

Gastroenterology. 2001 Aug;121(2):275-81.

PMID:
11487537
46.

Intestinal amebiasis: a diagnosis not to be missed.

Marcus VA, Ward BJ, Jutras P.

Pathol Res Pract. 2001;197(4):271-4; discussion 275-8.

PMID:
11358014
47.

Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis.

Thompson-Fawcett MW, Marcus VA, Redston M, Cohen Z, Mcleod RS.

Dis Colon Rectum. 2001 Mar;44(3):347-53.

PMID:
11289279
48.

Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.

Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Choti M, Zahurak M, Johnson K, Tascilar M, Offerhaus GJ, Hruban RH, Kern SE.

Am J Pathol. 2000 May;156(5):1641-51.

49.

Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.

Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LK, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M.

Am J Surg Pathol. 1999 Oct;23(10):1248-55.

PMID:
10524526
50.

Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium.

Millar AL, Pal T, Madlensky L, Sherman C, Temple L, Mitri A, Cheng H, Marcus V, Gallinger S, Redston M, Bapat B, Narod S.

Hum Mol Genet. 1999 May;8(5):823-9.

PMID:
10196371

Supplemental Content

Loading ...
Support Center